About ▼ Careers Internship MedBlog Contact us

GW Formally Launches New GW Cancer Center

GW makes a historic commitment in the fight against cancer, holding a ribbon-cutting ceremony and grand opening celebration for the new GW Cancer Center

George Washington University leaders and cancer research advocates celebrate the official opening of the GW Cancer Center Wednesday. The GWCC will focus on interdisciplinary research and patient care. (courtesy: Logan Werlinger/GW)

Latest Press Release on Cancer News

Infinitopes' Article in Peer-Reviewed Journal Seeks to Unlock the Potential of Cancer Vaccines

Publication in Human Vaccines and Immunotherapeutics highlights progress in understanding tumour biology and vaccine technologies since the pandemic OXFORD, England , May 9, 2...

Commit Biologics launches with €16m seed financing to pioneer complement system activation to treat cancer and autoimmune disease

Financing led by Bioqube Ventures and Novo Holdings Commit is pioneering a novel approach to activating the complement component of the immune system to treat cancer and autoimmun...

Debbie's Dream Foundation: Curing Stomach Cancer Supports Pioneering Gastroesophageal Cancer Research Retreat

DDF invites the stomach cancer community to participate in the live Patient Advocacy and Case Discussion via Zoom. NEW YORK , May 8, 2024 /PRNewswire/ -- Debbie's Dream Founda...

Acepodia Announces Preliminary Clinical Data From Phase 1 Clinical Trial of ACE1831, First-Ever Anti-CD20 Antibody Conjugated Allogenic Gamma Delta T Cell Therapy for Non-Hodgkins Lymphoma

First dosing dohort was completed with complete response and disease stabilization identified at three months at the lowest dose level in the Phase 1 study No ACE1831-related serio...

Minghui Pharmaceutical to Present the Phase I/II Study of MHB088C (B7-H3 ADC) for the Treatment of Patients with Recurrent or Metastatic Solid Tumors in Late-breaking Oral Presentation at the 2024 ASCO Annual Meeting

SHANGHAI , May 8, 2024 /PRNewswire/ -- Minghui Pharmaceutical, Inc., a late-stage clinical biopharmaceutical company focused on autoimmune diseases and oncology, will feature Dr. ...

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use Ok, Got it. Close